|
ALDH5A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.61729996062121E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.20439999587541E-08 |
| Normal-vs-Stage2 |
1.212240E-04 |
| Normal-vs-Stage3 |
3.001100E-03 |
| Normal-vs-Stage4 |
6.838200E-03 |
| Stage1-vs-Stage2 |
7.046000E-01 |
| Stage1-vs-Stage3 |
4.323800E-01 |
| Stage1-vs-Stage4 |
5.237400E-01 |
| Stage2-vs-Stage3 |
7.254800E-01 |
| Stage2-vs-Stage4 |
7.572400E-01 |
| Stage3-vs-Stage4 |
9.914400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.92940149704668E-11 |
| Normal-vs-AfricanAmerican |
2.64959999995984E-06 |
| Normal-vs-Asian |
7.184200E-01 |
| Caucasian-vs-AfricanAmerican |
2.364800E-01 |
| Caucasian-vs-Asian |
4.733000E-01 |
| AfricanAmerican-vs-Asian |
5.671800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.34400268692048E-11 |
| Normal-vs-Female |
2.31399999999216E-05 |
| Male-vs-Female |
8.251700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.21129999994552E-06 |
| Normal-vs-Extreme_Weight |
1.66311409088848E-12 |
| Normal-vs-Obese |
3.46060000000481E-06 |
| Normal-vs-Extreme_Obese |
2.817400E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.429180E-01 |
| Normal_Weight-vs-Obese |
8.480400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.700600E-01 |
| Extreme_Weight-vs-Obese |
5.680000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.349800E-01 |
| Obese-vs-Extreme_Obese |
8.563600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.49450000153095E-08 |
| Normal-vs-Age(41-60Yrs) |
4.81800044305203E-10 |
| Normal-vs-Age(61-80Yrs) |
4.30880000013012E-07 |
| Normal-vs-Age(81-100Yrs) |
2.049000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.343000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.904640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.829600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.249600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.238600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.886600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.08270004073319E-09 |
| Normal-VS-Type2 PRCC |
8.104800E-03 |
| Normal-VS-KIRP CIMP |
5.80610000078252E-08 |
| Normal-VS-Unclassified PRCC |
9.03789998396576E-09 |
| Type1 PRCC-VS-Type2 PRCC |
8.622000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.496200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.952800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.078900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.544700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.832800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.55729999995469E-06 |
| Normal-vs-N1 |
2.143800E-03 |
| Normal-vs-N2 |
5.18063369980837E-12 |
| N0-vs-N1 |
2.885400E-01 |
| N0-vs-N2 |
7.627600E-04 |
| N1-vs-N2 |
8.624000E-04 |
|
|
